Literature DB >> 4506001

Osteosarcoma. An assessment of management with particular reference to primary irradiation and selective delayed amputation.

R D Jenkin, W E Allt, P J Fitzpatrick.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4506001     DOI： 10.1002/1097-0142(197208)30:2<393::aid-cncr2820300215>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  [Carcinochemotherapy in pediatric surgery (author's transl)].

Authors:  G Hollmann; F Lampert
Journal:  Langenbecks Arch Chir       Date:  1975-11

2.  Primary intracerebral osteosarcoma: a case report.

Authors:  G S Bauman; W M Wara; S F Ciricillo; R L Davis; S Zoger; M S Edwards
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Osteosarcoma: the contribution of radiotherapy.

Authors:  G E Flatman
Journal:  Proc R Soc Med       Date:  1976-08

4.  Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.

Authors:  David M Loeb; Robert F Hobbs; Amarachukwu Okoli; Allen R Chen; Steve Cho; Senthamizhchelvan Srinivasan; George Sgouros; Ori Shokek; Moody D Wharam; Tammy Scott; Cindy L Schwartz
Journal:  Cancer       Date:  2010-08-16       Impact factor: 6.860

5.  [The role of radiotherapy in the treatment of malignant bone tumors (author's transl)].

Authors:  E Scherer; R Weber
Journal:  Langenbecks Arch Chir       Date:  1975-11

6.  Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Authors:  David M Loeb; Elizabeth Garrett-Mayer; Robert F Hobbs; Andrew R Prideaux; George Sgouros; Ori Shokek; Moody D Wharam; Tammy Scott; Cindy L Schwartz
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

7.  Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.

Authors:  Breelyn A Wilky; David M Loeb
Journal:  Clin Exp Pharmacol       Date:  2013-06

8.  The activity level of follicular helper T cells in the peripheral blood of osteosarcoma patients is associated with poor prognosis.

Authors:  Jianshu Lu; Xiuqin Kang; Zhitao Wang; Gang Zhao; Baoen Jiang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  A radiotherapy technique to improve dose homogeneity around bone prostheses.

Authors:  M V Williams; N G Burnet; E Sherwin; R Kestelman; A R Geater; S J Thomas; C B Wilson
Journal:  Sarcoma       Date:  2004
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.